AI assistant
Sending…
DEXCOM INC — Director's Dealing 2010
Aug 18, 2010
30198_dirs_2010-08-18_aa4ecaf3-7b61-4b8a-b6e2-7c06205ac565.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2010-08-16
Reporting Person: CARNER DAVID (VP, Quality Assurance)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-08-16 | Incentive Stock Option (right to buy) | $12.73 | A | 31420 | Acquired | 2020-08-16 | Common Stock (31420) | Direct |
| 2010-08-16 | Non-Qualified Stock Option (right to buy) | $12.73 | A | 68580 | Acquired | 2020-08-16 | Common Stock (68580) | Direct |
Footnotes
F1: The option vests and becomes exercisable with respect to 1/4th of the shares one year after the date of grant, and thereafter continues to vest and become exercisable as to 1/48th of the shares each month thereafter (with the shares fully vested on the 4th anniversary of the date of grant).
F2: Not applicable
More from DEXCOM INC
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 15
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 2
Director's Dealing
2026
Feb 26
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 17